Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] Investigating the effect of tamsulosin on the measurement of bladder wall thickness and International Prostate Symptom Score in benign prostatic hyperplasia
    Eghbali, Kamyar
    Shayegan, Mohammad Reza
    Kianoush, Sina
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (5-6): : E317 - E321
  • [22] Cost analysis of alpha blocker treatments for benign prostatic hyperplasia in Medicare beneficiaries
    Sidi, Yulia
    Duan, Yinghui
    Rhee, Taeho Greg
    Wu, Z. Helen
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (06) : 1119 - 1139
  • [23] THE USE OF ALPHA BLOCKERS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Atan, Ali
    Aslan, Yilmaz
    Tuncel, Altug
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2012, 15 (02): : 237 - 240
  • [24] Therapeutic effect of solifenacin combined with tamsulosin on benign prostatic hyperplasia with overactive bladder
    Chen, Siping
    Wen, Huihuang
    Zhou, Bin
    Li, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13820 - 13826
  • [25] Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia
    Lepor, Herbert
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 311 - +
  • [26] Comparison of Tamsulosin Plus Serenoa Repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study
    Ryu, Young Woo
    Linn, Song Won
    Kinn, Jung Noon
    Ahn, Seung Hyun
    Choi, Jae Duck
    UROLOGIA INTERNATIONALIS, 2015, 94 (02) : 187 - 193
  • [27] A prospective study of the efficacy of Serenoa repens, Tamsulosin, and Serenoa repens plus Tamsulosin treatment for patients with benign prostate hyperplasia
    Fatih Hızlı
    M. Cemil Uygur
    International Urology and Nephrology, 2007, 39 : 879 - 886
  • [28] A prospective study of the efficacy of Serenoa repens, Tamsulosin, and Serenoa repens plus Tamsulosin treatment for patients with benign prostate hyperplasia
    Hizli, Fatih
    Uygur, M. Cemil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (03) : 879 - 886
  • [29] Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?
    Loeb, Stacy
    Gupta, Angela
    Losonczy, Lia
    Tosoian, Jeffrey
    Walsh, Patrick C.
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 2 - 4
  • [30] Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
    Barkin, Jack
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 483 - 490
12345